Efficacy and Safety of a Low-Level Light Therapy for Androgenetic Alopecia: A 24-Week, Randomized, Double-Blind, Self-Comparison, Sham Device-Controlled Trial

    November 2018 in “Dermatologic Surgery
    Sabrina Mai-Yi Fan, Yu-Pin Cheng, Ming-Yung Lee, Sung-Jan Lin, Hsien-Yi Chiu
    Image of study
    TLDR Low-level light therapy safely improves hair coverage, thickness, and count in androgenetic alopecia patients.
    A 24-week randomized, double-blind, self-comparison, sham device-controlled trial was conducted to evaluate the efficacy and safety of low-level light therapy (LLLT) for androgenetic alopecia (AGA). The study found that LLLT was effective in increasing hair coverage, thickness, and count in patients with AGA compared to sham treatment controls. The study suggests that LLLT may be a safe and well-tolerated treatment for AGA. No serious adverse events were observed.
    View this study on journals.lww.com →

    Cited in this study

    Related